Leveraging Data Science to Power Precision Oncology
Our new report examines the current state of oncology clinical development and the opportunity to leverage significant volumes of contextualized patient data to accurately profile patients, generate digital twins, accelerate clinical trials and power precision oncology. Using Phesi’s AI-powered Trial Accelerator™ with data from 167 million patients, our global analysis shows colorectal cancer has the largest volume of real-world data.
Now with 40 different Digital Patient Profiles including Breast Cancer with PIK3CA and Diffuse Large B Cell Lymphoma. Each profile provides an accurate picture of the patient population to enable greater precision in trial design and execution, using key demographics including age, sex, comorbidities, outcome measures and concomitant medications.
Read our recent Nature publication to discover the potential of AI-powered digital twins. The study demonstrates how real-world clinical data can be used to create virtual digital twin cohorts instead of placebo and standard-of-care comparator arms.
